DP

Deepak Patel

Active Director Director DIN 08177653
DIN 08177653 First appointment Jul 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2018
Shareholding value •••• Premium profile

About Deepak Patel

Data last updated:

Deepak Patel is a Director at Conset Pharma Private Limited (since 2018). The company operates in Pharma. Conset Pharma Private Limited reported revenue of ₹2.69 Cr (FY 2024).

DIN 08177653
Primary Designation Director
Industry Pharma
First Appointment 16 Jul 2018
Oldest Company Age 15 yrs
Largest company Conset Pharma Private Limited · ₹2.69 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Conset Pharma Private Limited U51397MP2011PTC025290
Director16 Jul 20182011₹2.69 Cr (FY 2024)Active

Board colleagues of Deepak Patel

NameDINCompanyDesignation
Sita Patel03398037Conset Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Conset Pharma Private Limited
Premium access

Shareholding and investment profile for Deepak Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Patel

Deepak Patel currently holds 1 directorship: Conset Pharma Private Limited (Director, since 16 Jul 2018, revenue ₹2.69 Cr (FY 2024)).

Deepak Patel was first appointed on 16 Jul 2018 as Director at Conset Pharma Private Limited.

The current boards of Deepak Patel's companies include Sita Patel (Conset Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available